XTX Topco’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Buy |
73,675
+31,849
| +76% | +$47.1K | ﹤0.01% | 1867 |
|
|
2025
Q1 | $107K | Buy |
+41,826
| New | +$107K | 0.01% | 1856 |
|
|
2024
Q4 | – | Sell |
-35,058
| Closed | -$35.8K | – | 2778 |
|
|
2024
Q3 | $35.8K | Buy |
+35,058
| New | +$35.8K | ﹤0.01% | 1747 |
|
|
2024
Q1 | – | Sell |
-18,750
| Closed | -$33.4K | – | 2211 |
|
|
2023
Q4 | $33.4K | Sell |
18,750
-65,223
| -78% | -$116K | 0.01% | 1296 |
|
|
2023
Q3 | $139K | Sell |
83,973
-86,905
| -51% | -$144K | 0.02% | 1124 |
|
|
2023
Q2 | $342K | Buy |
170,878
+136,814
| +402% | +$274K | 0.06% | 622 |
|
|
2023
Q1 | $71.5K | Buy |
+34,064
| New | +$71.5K | 0.02% | 1132 |
|
|
2021
Q4 | – | Sell |
-20,514
| Closed | -$27K | – | 935 |
|
|
2021
Q3 | $27K | Buy |
20,514
+3,366
| +20% | +$4.43K | 0.01% | 633 |
|
|
2021
Q2 | $33K | Buy |
+17,148
| New | +$33K | 0.01% | 747 |
|